Letter/Communication
A Novel Approach to Treating Refractory Immune Thrombocytopenia
NEJM journal watch. Oncology & hematology
07/02/2024
Abstract
Targeting antibody-producing cells using an anti-CD38 monoclonal antibody shows promise as a treatment for adults with relapsed or refractory ITP.
Details
- Title: Subtitle
- A Novel Approach to Treating Refractory Immune Thrombocytopenia
- Creators
- Anjali Sharathkumar
- Resource Type
- Letter/Communication
- Publication Details
- NEJM journal watch. Oncology & hematology
- Publisher
- Massachusetts Medical Society
- ISSN
- 2330-0426
- Language
- English
- Date published
- 07/02/2024
- Academic Unit
- Stead Family Department of Pediatrics; Hematology/Oncology
- Record Identifier
- 9984652157302771
Metrics
6 Record Views